ERYFF
Erytech Pharma - Ordinary Share

0
52W High
$0.0001
Volume
150.00
52W Low
$0.0001
Price
$0.0001
Open
$0.0001
ERYFF Fundamentals
50D MA
$0.00
Beta
0.00
Avg. Volume
6.52
Loading...
Loading...
PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for PHAXIAM Therapeutics S.A. - Ordinary Share?
What is the 52-week low for PHAXIAM Therapeutics S.A. - Ordinary Share?
What is PHAXIAM Therapeutics S.A. - Ordinary Share stock price today?
What is the 50-day moving average of PHAXIAM Therapeutics S.A. - Ordinary Share?

Latest ERYFF News

View
No ERYFF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.